Overview

MelaViD: A Trial on Vitamin D Supplementation for Resected Stage II Melanoma Patients

Status:
Terminated
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to assess the effect of vitamin D supplementation on recurrence in resected stage II melanoma patients.
Phase:
Phase 3
Details
Lead Sponsor:
European Institute of Oncology
Treatments:
Cholecalciferol
Ergocalciferols
Vitamin D
Vitamins